RT Journal Article
SR Electronic
T1 An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000883
DO 10.1136/jitc-2020-000883
VO 8
IS 2
A1 Taylor, Kirsty
A1 Loo Yau, Helen
A1 Chakravarthy, Ankur
A1 Wang, Ben
A1 Shen, Shu Yi
A1 Ettayebi, Ilias
A1 Ishak, Charles A
A1 Bedard, Philippe L
A1 Abdul Razak, Albiruni
A1 R Hansen, Aaron
A1 Spreafico, Anna
A1 Cescon, Dave
A1 Butler, Marcus O
A1 Oza, Amit M
A1 Lheureux, Stephanie
A1 Stjepanovic, Neda
A1 Van As, Brendan
A1 Boross-Harmer, Sarah
A1 Wang, Lisa
A1 Pugh, Trevor J
A1 Ohashi, Pamela S
A1 Siu, Lillian L
A1 De Carvalho, Daniel D
YR 2020
UL http://jitc.bmj.com/content/8/2/e000883.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.